Manuel Lobato is the partner who leads Bird & Bird intellectual property team in Spain.
He specialises in intellectual property and pharmaceutical law. Manuel has a strong litigation experience on pharmaceutical and mechanical patents and has extensively advised on the drafting of technology transfer contracts. His experience also encompasses commercial and corporate law matters arising from joint ventures, due diligences and contractual work.
He was previously a partner at both Gomez-Acebo & Pombo and Baker & McKenzie.
He is a professor of law at the Autonomous University of Madrid. He regularly lectures on intellectual property law and pharmaceutical law in Latin American countries at seminars organised by several universities (Católica of Lima, Javeriana and Savana in Colombia, etc), judicial schools (Costa Rica, Guatemala, Honduras and Spain). He has intervened as expert at Procompetencia in Venezuela and at the Court of Justice of the Andean Community in pharmaceutical data exclusivity and patent law matters (case 01-AI-2001).
As a researcher, he is the author of legal publications on intellectual property law (patent, trademark and copyright), insolvency law and contract law. His exhaustive commentary on the New Spanish Trade Mark Act (1,200 pages long) has been quoted several times in rulings by the Spanish Commercial Courts. His works have been quoted by the advocate general in several cases at the ECJ: C-495/07 (Silberquelle, on trademarks), C-102/07 (Adidas, on trademarks), C-206/04 (Mülhens on international private law questions), C-465 and 466/02 (Denmark/Commission, on appellations of origin).
This biography is an extract from The International Who's Who of Life Sciences Lawyers which can be purchased from our Shop.
Manuel Lobato also features in the following practice areas:
It is not possible to buy entry into any Who's Who Legal publication
Nominees have been selected based upon comprehensive, independent survey work with both general counsel and private practice lawyers worldwide. Only specialists who have met independent international research criteria are listed.